Q4 2023 Dare Bioscience Inc Earnings Call Transcript
Welcome to the conference call hosted by Daré Bioscience to review the company's fourth quarter financial results and to provide a general business update. This call is being recorded. My name is Lisa and I will be your operator today. With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer; and MarDee Haring-Layton, Chief Accounting Officer. Ms. Johnson, please proceed.
Thank you. Good afternoon, and welcome to the Daré Bioscience financial results and business update call for the year ended December 31, 2023. Today, we'll review our financial results for 2023 and discuss developments and expectations for our pipeline and portfolio. Before we began, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any statements made during this call that are not
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |